Xanomeline/Trospium Chloride is named as a drug or biological intervention in 7 clinical trials in our USA, UK, India and China trial registers, 6 of which are recruiting. Lead sponsors include Bristol-Myers Squibb (6) and Karuna Therapeutics, Inc., a Bristol Myers Squibb company (1). Registered phases: Phase 3, Phase 1, Observational and Phase 4. Conditions studied include Schizophrenia; Healthy Volunteers; Alzheimer's Disease.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Schizophrenia | 3 |
| Healthy Volunteers | 1 |
| Alzheimer's Disease | 1 |
| Alzheimer Disease | 1 |
| Mania | 1 |
| Bipolar Disorder | 1 |
| Lead sponsor | Trials |
|---|---|
| Bristol-Myers Squibb | 6 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 1 |
| Register | Xanomeline/Trospium Chloride trials |
|---|---|
| Clinical trials in USA | 6 |
| Clinical trials in UK | 3 |
| Clinical trials in India | 2 |
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Xanomeline/Trospium Chloride works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Xanomeline/Trospium Chloride (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.